(Q39880948)

15 September 2017

EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells (English)

1 reference

15 September 2017

1 reference

neoplastic invasiveness

1 reference

B P Fox

1

1 reference

15 September 2017

R P Kandpal

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

23 February 2009

1 reference

15 September 2017

1 reference

15 September 2017

28

1 reference

15 September 2017

1706-1713

1 reference

15 September 2017

14

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2009.18

15 September 2017

0 references

cites work

Accelerated apoptosis in the Timp-3-deficient mammary gland

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Cross-linking of EphB6 resulting in signal transduction and apoptosis in Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Vascular patterning by Eph receptor tyrosine kinases and ephrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Understanding cancer metastasis: an urgent need for using differential gene expression analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Breast tumor cell lines from pleural effusions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Dissemination and growth of cancer cells in metastatic sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The Eph family in the patterning of neural development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Eph receptors and ephrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Regulation of repulsion versus adhesion by different splice forms of an Eph receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

31 March 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Mechanisms and functions of Eph and ephrin signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Identification of the Jak/Stat proteins as novel downstream targets of EphA4 signaling in muscle: implications in the regulation of acetylcholinesterase expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Matrix metalloproteinases (MMPs) in health and disease: an overview

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The protein kinase complement of the human genome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Expression of a kinase-defective Eph-like receptor in the normal human brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Abnormal TNF activity in Timp3 −/− mice leads to chronic hepatic inflammation and failure of liver regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Chromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Eph receptors and ephrins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Eph receptor signalling casts a wide net on cell behaviour

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Frequent epigenetic inactivation of cystatin M in breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

A human cell line from a pleural effusion derived from a breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The role of ephrins and Eph receptors in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

The C-terminus of ephrin-B1 regulates metalloproteinase secretion and invasion of cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Prognostic significance ofEPHB6, EFNB2, andEFNB3 expressions in neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor‐1 in human breast cancer cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

An Eph receptor regulates integrin activity through R-Ras

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2009.18

31 March 2020

Identifiers

DOI

10.1038/ONC.2009.18

1 reference

release_lzpvgdj35ja5npijoo7hrh5as4

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lzpvgdj35ja5npijoo7hrh5as4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference